InflaRx IFRX
NASDAQ IFRX
$2.05 -0.04 (-1.91%)
As of: Sep 10, 2026 · 3:59 PM EDT

InflaRx (IFRX) Times Interest Earned (2016 - 2026)

InflaRx's (IFRX) quarterly Times Interest Earned came in at 481.53 in Q2 2026, down 87.49% year-over-year from 3850.37 in Q2 2025, and down 1.07% quarter-over-quarter from 486.74 in Q1 2026.

Analysis

InflaRx (IFRX) Times Interest Earned (2016 - 2026) Analysis & Trends

InflaRx has disclosed Times Interest Earned across 11 years of filings, most recently posting 481.53 for Q2 2026.

  • In Q2 2026, Times Interest Earned fell 87.49% year-over-year to 481.53; the TTM figure through Jun 2026 stood at 597.43 (down 79.06% YoY), while the FY2025 annual figure was 1229.88, down 52.08% from the prior year.
  • Times Interest Earned came in at 481.53 for Q2 2026 at InflaRx, down from 486.74 in the prior quarter.
  • In the past five years, Times Interest Earned ranged from a high of 3850.37 in Q2 2025 to a low of 136.77 in Q2 2022.
  • Average Times Interest Earned over 5 years is 1643.96, with a median of 1511.86 recorded in 2024.
  • Year-over-year, Times Interest Earned slumped 97.02% in 2022 and surged 1326.41% in 2023.
  • Over 5 years, Times Interest Earned stood at 712.44 in 2022, then surged by 76.92% to 1260.47 in 2023, then surged by 103.61% to 2566.39 in 2024, then plunged by 71.27% to 737.39 in 2025, then plunged by 34.7% to 481.53 in 2026.
  • Per Business Quant data, the three most recent Times Interest Earned figures were 481.53 in Q2 2026, 486.74 in Q1 2026, and 737.39 in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Times Interest Earned (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 5.22
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn -42.08
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 117.59
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn 493.00
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn 2.82
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn -
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn -
10 InflaRx 139.29 Mn -44.96 Mn 2.74 Mn -481.53
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 481.53
Mar 31, 2026 486.74
Dec 31, 2025 737.39
Sep 30, 2025 660.00
Jun 30, 2025 3,850.37
Mar 31, 2025 3,182.85
Dec 31, 2024 2,566.39
Sep 30, 2024 3,052.47
Jun 30, 2024 1,763.25
Mar 31, 2024 2,696.18
Dec 31, 2023 1,260.47
Sep 30, 2023 2,277.08
Jun 30, 2023 1,950.94
Mar 31, 2023 1,916.58
Dec 31, 2022 712.44
Sep 30, 2022 1,255.55
Jun 30, 2022 136.77
Mar 31, 2022 604.34
Dec 31, 2021 1,923.16
Sep 30, 2021 1,336.48